Differentiation of thrombin- and factor Xa-related amidolytic activity in plasma by means of a synthetic thrombin inhibitor.
D000814:Aniline Compounds / Q000032:analysis; D002863:Chromogenic Compounds; D004151:Dipeptides; D004789:Enzyme Activation / Q000187:drug effects; D004792:Enzyme Precursors / Q000378:metabolism; D005170:Factor X / Q000378:metabolism*; D015951:Factor Xa; D006801:Humans; D007700:Kinetics; D010880:Piperidines / Q000494:pharmacology*; D010949:Plasma / Q000032:analysis; D011480:Protease Inhibitors; D012697:Serine Endopeptidases; D013917:Thrombin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013925:Thromboplastin / Q000494:pharmacology
D000814:Aniline Compounds; D002863:Chromogenic Compounds; D004151:Dipeptides; D004792:Enzyme Precursors; D010880:Piperidines; D011480:Protease Inhibitors; C008625:nitroaniline; C038708:N(alpha)-(2-naphthylsulfonylglycyl)-4-amidinophenylalanine piperidide; D005170:Factor X; D013925:Thromboplastin; D012697:Serine Endopeptidases; D013917:Thrombin; D015951:Factor Xa